Medtronic (NYSE:MDT) and UnitedHealthcare (NYSE:UNH) today touted first-year results from a 6,000-person analysis designed to compare hospital admission rates between people with diabetes using insulin pumps and people controlling their diabetes with multiple daily injections of insulin. The study included people using Medtronic’s MiniMed 630G system, as well as previous iterations of the medtech giant’s insulin pumps. […]
FDA launches medical device innovation challenge to combat opioid crisis
The U.S. FDA today announced that it has launched an innovation challenge to encourage the development of medical devices to help reduce the country’s opioid abuse crisis. The hope is that the challenge will result in new medtech including digital health technologies and diagnostic tests to help detect, treat and prevent addiction, according to FDA. Go […]
Medtech stories we missed this week: May 25, 2018
From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press release that it has received FDA 510(k) clearance […]
Ascensia Diabetes Care launches upgraded blood glucose monitor app
Ascensia Diabetes Care announced today the launch of an upgraded version of its Contour Diabetes app in 24 countries. The latest version of the company’s app includes algorithms to analyze blood glucose data collected from the Contour Next One meter and gives personalized feedback to users. The upgraded app was recently launched in Austria, Belgium, Canada, […]
Fitbit unveils array of new apps from health partners
Fitbit (NYSE:FIT) revealed today a suite of new apps and clock faces designed to help people manage their health, including a glucose monitoring app from Dexcom (NSDQ:DXCM) that is slated to launch in the second half of 2018. The Las Vegas-based company also announced programming from Diplomat Pharmacy, Humana (NYSE:HUM), One Drop and Walgreens. “Smartwatches provide a […]
Common Sensing, Haselmeier ink deal to develop connected injection pen
Swiss-based manufacturer Haselmeier inked a deal with Common Sensing to develop a smart, connected drug-delivery device for people who use injectable medications. The companies plan to combine Haselmeier’s subcutaneous injection technology with Common Sensing’s Gocap injector monitor. The product, which will be sold by Haselmeier, will record the time and dose of every injection and […]
DHS warns on cyber vulnerability with BD’s Pyxis drug-dispensing devices
An array of medication-management systems from Becton Dickinson (NYSE: BDX) are vulnerable to the industry-wide KRACK key-reinstallation cyber attack, according to the company and to the Dept. of Homeland Security. The glitch, which was first reported last year, is a vulnerability in the WPA2 protocol for securing Wi-Fi that can imperil the confidentiality and integrity of communication […]
This new PTFE seal could make insulin pumps and other medical devices better
In dynamic applications requiring sealing at low-to-moderate speeds and pressures, design engineers are replacing underperforming elastomeric O-rings with spring-energized PTFE “C-ring” seals. David Wang, Bal Seal Engineering When O-rings and other traditional sealing methods fail, diagnostic and drug-delivery equipment engineers are embracing a new and more cost-effective way to improve the performance of their existing […]
Livongo Health acquires weight-management, disease-prevention dev Retrofit
Livongo Health said yesterday it acquired weight-management and disease-prevention program developer Retrofit for an undisclosed amount. With the acquisition, Mountain View, Calif.-based Livongo Health said it will make Retrofit’s Diabetes Prevention program available as Livongo DPP, powered by Retrofit. Livongo said the acquisition acts as a compliment to its Livongo for Diabetes and Livongo for Hypertension […]
Livongo raises $105m for digital diabetes management platform
Livongo Health closed a $105 million round led by a group of investors including General Catalyst, Merck Global Health Innovation Fund and Echo Health Ventures. The Mountain View, Calif.-based company has developed Livongo for Diabetes – a collection of connected devices that enable people with diabetes to interact with a virtual care team. “We are particularly […]
Drug Delivery Business News
@DrugDeliveryNow
LinkedIn